X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2855) 2855
science & technology (2522) 2522
life sciences & biomedicine (2426) 2426
male (2078) 2078
female (2048) 2048
adult (1728) 1728
transplantation (1651) 1651
middle aged (1520) 1520
graft vs host disease - epidemiology (1288) 1288
hematology (1275) 1275
adolescent (1257) 1257
risk factors (956) 956
child (917) 917
retrospective studies (908) 908
immunology (901) 901
incidence (802) 802
transplantation, homologous (780) 780
oncology (724) 724
hematopoietic stem cell transplantation - adverse effects (718) 718
treatment outcome (710) 710
child, preschool (687) 687
aged (681) 681
graft vs host disease - etiology (650) 650
hematopoietic stem cells (629) 629
stem cells (563) 563
graft vs host disease - prevention & control (558) 558
young adult (552) 552
hematopoietic stem cell transplantation (478) 478
infant (459) 459
follow-up studies (441) 441
health aspects (439) 439
biophysics (389) 389
survival analysis (388) 388
bone marrow transplantation (383) 383
abridged index medicus (365) 365
surgery (359) 359
transplants & implants (356) 356
acute disease (344) 344
graft survival (340) 340
bone marrow transplantation - adverse effects (339) 339
immunosuppressive agents - therapeutic use (326) 326
recurrence (325) 325
mortality (311) 311
survival rate (309) 309
analysis (300) 300
stem cell transplantation (300) 300
prognosis (293) 293
bone marrow (288) 288
time factors (286) 286
chronic disease (285) 285
tissue donors (284) 284
disease-free survival (281) 281
graft vs host disease - immunology (273) 273
research (269) 269
care and treatment (264) 264
transplantation conditioning - methods (262) 262
hematopoietic stem cell transplantation - methods (261) 261
hematologic neoplasms - therapy (246) 246
graft vs host disease - mortality (243) 243
graft-versus-host reaction (243) 243
graft-versus-host disease (241) 241
transplantation, homologous - adverse effects (240) 240
transplantation conditioning (235) 235
patients (234) 234
prospective studies (229) 229
infectious diseases (223) 223
allografts (221) 221
syngeneic grafts (218) 218
pediatrics (217) 217
cohort studies (199) 199
leukemia - therapy (195) 195
histocompatibility testing (194) 194
animals (193) 193
infections (190) 190
multivariate analysis (189) 189
medicine & public health (186) 186
graft vs host disease - diagnosis (185) 185
complications and side effects (182) 182
graft rejection (182) 182
graft vs host disease - complications (173) 173
leukemia (173) 173
hematopoietic stem cell transplantation - mortality (169) 169
hemopoiesis (165) 165
graft rejection - epidemiology (164) 164
hematology, oncology and palliative medicine (160) 160
cancer (159) 159
surgical procedures, operative (157) 157
bone marrow transplantation - mortality (156) 156
children (154) 154
graft versus host reaction (153) 153
liver (153) 153
graft vs host disease (152) 152
kidney transplantation (152) 152
patient outcomes (152) 152
liver transplantation (147) 147
survival (147) 147
diagnosis (146) 146
bone marrow transplantation - immunology (145) 145
graft vs host disease - drug therapy (145) 145
immunosuppressive agents - adverse effects (145) 145
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3119) 3119
Chinese (40) 40
Japanese (28) 28
Spanish (17) 17
French (16) 16
German (11) 11
Portuguese (6) 6
Polish (5) 5
Italian (4) 4
Dutch (2) 2
Norwegian (2) 2
Korean (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2009, Volume 373, Issue 9674, pp. 1550 - 1561
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2010, Volume 363, Issue 22, pp. 2091 - 2101
.... Infections, graft-versus-host disease (GVHD), and liver, kidney, and pulmonary complications have been associated with high mortality after allogeneic hematopoietic-cell transplantation since the introduction of this procedure 40 years ago... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Graft vs Host Disease - epidemiology | Multiple Myeloma - mortality | Humans | Middle Aged | Child, Preschool | Infant | Hematopoietic Stem Cell Transplantation - mortality | Infection - etiology | Lung Diseases - etiology | Transplantation, Homologous - mortality | Young Adult | Multiple Myeloma - therapy | Myelodysplastic Syndromes - therapy | Infection - epidemiology | Graft vs Host Disease - mortality | Bone Marrow Diseases - therapy | Kidney Diseases - epidemiology | Liver Diseases - etiology | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Child | Bone Marrow Diseases - mortality | Leukemia - therapy | Mortality - trends | Liver Diseases - epidemiology | Bilirubin - blood | Lymphoma, Non-Hodgkin - therapy | Adolescent | Creatinine - blood | Aged | Lymphoma, Non-Hodgkin - mortality | Kidney Diseases - etiology | Lung Diseases - epidemiology | Leukemia - mortality | United States | Mortality | Patient outcomes | Graft versus host reaction | Transplantation | Risk factors | Hematopoietic stem cells | Cytomegalovirus | Fungal infections | Nosocomial infections | Transplants & implants | Drug dosages | Index Medicus | Abridged Index Medicus | comparative outcomes research | ursodiol | liver disease | hematopoietic cell transplantation | pulmonary disease | Marrow transplantation | survival | mortality | kidney disease | graft-vs.-host disease | infectious complications
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2016, Volume 374, Issue 1, pp. 43 - 53
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2013, Volume 19, Issue 3, pp. 405 - 409
... to engraftment, growth factor administration, and occurrence of graft-versus-host disease were assessed as potential risk factors for the development of CDAD... 
Hematology, Oncology and Palliative Medicine | Antibiotics | Stem cell transplantation | Clostridium difficile | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Age Factors | Humans | Middle Aged | Gram-Positive Bacterial Infections - mortality | Male | Enterocolitis, Pseudomembranous - microbiology | Clostridium difficile - isolation & purification | Graft vs Host Disease - immunology | Enterococcus faecium - isolation & purification | Transplantation, Homologous | Incidence | Anti-Bacterial Agents - therapeutic use | Enterocolitis, Pseudomembranous - mortality | Graft vs Host Disease - mortality | Gram-Positive Bacterial Infections - microbiology | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Chicago - epidemiology | Aztreonam - therapeutic use | Ciprofloxacin - therapeutic use | Risk Factors | Vancomycin Resistance | Survival Rate | Gram-Positive Bacterial Infections - etiology | Graft vs Host Disease - pathology | Enterocolitis, Pseudomembranous - etiology | Enterocolitis, Pseudomembranous - drug therapy | Vancomycin - therapeutic use | Clostridium difficile - growth & development | Aged | Enterococcus faecium - growth & development | Gram-Positive Bacterial Infections - drug therapy | Chemotherapy | Analysis | Mortality | Stem cells | Ciprofloxacin | Health aspects | Epidemiology | Hematopoietic stem cells | Cancer | Index Medicus
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 6, pp. 1117 - 1126
Abstract The China Assessment of Antifungal Therapy in Hematological Disease study, the first large-scale observational study of invasive fungal disease (IFD... 
Hematology, Oncology and Palliative Medicine | Allogeneic | Autologous | China | Fungal infection | Stem cells | Transplant | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic Neoplasms - therapy | Myeloablative Agonists - therapeutic use | Prognosis | Prospective Studies | Hematologic Neoplasms - mortality | Humans | Immunosuppressive Agents - therapeutic use | Mycoses - microbiology | Male | Transplantation, Autologous | Hematologic Neoplasms - pathology | Graft vs Host Disease - immunology | Transplantation, Homologous | Antifungal Agents - therapeutic use | Incidence | Neutropenia - etiology | Graft vs Host Disease - mortality | Neutropenia - microbiology | Hematopoietic Stem Cell Transplantation - adverse effects | Neutropenia - mortality | Adult | Female | Unrelated Donors | Siblings | Triazoles - therapeutic use | Risk Factors | Treatment Outcome | Neutropenia - drug therapy | Graft vs Host Disease - pathology | Adolescent | Mycoses - drug therapy | Survival Analysis | Graft vs Host Disease - prevention & control | Hematologic Neoplasms - immunology | Mycoses - mortality | Transplantation Conditioning | Chronic Disease | Mycoses - etiology | Medical research | Triazoles | Patient outcomes | Mortality | Mycoses | Medicine, Experimental | Health care industry | Epidemiology | Hematopoietic stem cells | Immunosuppressive agents | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 04/2012, Volume 379, Issue 9823, pp. 1301 - 1309
Summary Background Hepatic veno-occlusive disease is a leading cause of morbidity and mortality after haemopoietic stem-cell transplantation (HSCT... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Graft vs Host Disease - epidemiology | Humans | Child, Preschool | Infant | Male | Polydeoxyribonucleotides - therapeutic use | Hepatic Veno-Occlusive Disease - prevention & control | Hepatic Veno-Occlusive Disease - epidemiology | Renal Insufficiency - epidemiology | Incidence | Multiple Organ Failure - epidemiology | Bilirubin - blood | Fibrinolytic Agents - therapeutic use | Adolescent | Hematopoietic Stem Cell Transplantation - adverse effects | Female | Infusions, Intravenous | Child | Hepatic Veno-Occlusive Disease - drug therapy | Blood circulation disorders | Care and treatment | Surgery | Transplantation | Diagnosis | Children | Methods | Hematopoietic stem cells | Clinical trials | Gene expression | Mortality | Manuscripts | Risk factors | Abdomen | Side effects | Hospitals | Reviews | complications | clinical trials | Risk analysis | Morbidity | Index Medicus | Abridged Index Medicus | Pediatrics | Pediatrik | Bilirubin | Graft vs Host Disease | epidemiology | Renal Insufficiency | Hepatic Veno-Occlusive Disease | drug therapy | Intravenous | Infusions | Preschool | Hematopoietic Stem Cell Transplantation | prevention & control | Fibrinolytic Agents | blood | Polydeoxyribonucleotides | Multiple Organ Failure | adverse effects | therapeutic use
Journal Article